Optiver Holding
BOLD

Optiver Holding’s Boundless Bio BOLD Stock Holding History

Optiver Holding’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$185 Hold
168
– – ﹤0.01% 2222
2025
Q4 		$202 Hold
168
– – ﹤0.01% 2350
2025
Q3 		$207 Buy
+168
New +$194 ﹤0.01% 2580

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Optiver Holding's BOLD Position: Q1 2026 in Review

Optiver Holding held its Boundless Bio (BOLD) position steady in Q1 2026 at 168 shares worth $185. The position accounts for ﹤0.01% of the portfolio, ranked #2222.

Optiver Holding first reported a position in BOLD in Q3 2025 and has held it in 3 quarters since. The position peaked at $207 in Q3 2025. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • Optiver Holding held 168 shares of Boundless Bio worth $185 as of Q1 2026.
  • Optiver Holding left its Boundless Bio share count unchanged in Q1 2026.
  • Boundless Bio made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2222 holding.
  • Optiver Holding first reported a position in Boundless Bio in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Boundless Bio position peaked at $207 in Q3 2025.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.